Regen BioPharma Cash from Financing (TTM) Trends

Regen BioPharma Inc (RGBP)

0.705 +0.01 (+1.44%) USD | OTCM | May 17, 15:55

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	0.4725M
December 31, 2023	0.4095M
September 30, 2023	0.2438M
June 30, 2023	0.1005M
March 31, 2023	0.1005M
December 31, 2022	0.0005M
September 30, 2022	-0.094M
June 30, 2022	1.316M
March 31, 2022	1.269M
December 31, 2021	1.269M
September 30, 2021	1.363M
June 30, 2021	-0.0479M
March 31, 2021	0.00
December 31, 2020	0.0053M
September 30, 2020	-0.0265M
June 30, 2020	0.1165M
March 31, 2020	0.1705M
December 31, 2019	0.2687M
September 30, 2019	0.4318M
June 30, 2019	0.707M

Date	Value
March 31, 2019	0.7645M
December 31, 2018	0.8339M
September 30, 2018	1.322M
June 30, 2018	1.395M
March 31, 2018	1.989M
December 31, 2017	2.058M
September 30, 2017	2.140M
June 30, 2017	1.931M
March 31, 2017	1.671M
December 31, 2016	1.803M
September 30, 2016	1.658M
June 30, 2016	1.544M
March 31, 2016	1.174M
December 31, 2015	1.536M
September 30, 2015	1.231M
June 30, 2015	1.203M
March 31, 2015	1.223M
December 31, 2014	0.5367M
September 30, 2014	0.631M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.094M

Minimum

Sep 2022

1.363M

Maximum

Sep 2021

0.4038M

Average

0.2072M

Median

Cash from Financing (TTM) Benchmarks